Shingrix

Shingrix Indications/Uses

recombinant varicella-zoster virus glycoprotein e antigen vaccine

Manufacturer:

Distributor:

Marketer:

GlaxoSmithKline

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert

Full Prescribing Info

Indications/Uses

Shingrix is indicated for the prevention of herpes zoster (HZ) and HZ-related complications, such as post-herpetic neuralgia (PHN), in: adults 50 years of age or older; adults 18 years of age or older at increased risk of HZ.
The use of Shingrix should be based on official recommendations.

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in